NIAID Banner Logo Image


1. 59583 HIV-LS-363; PUBMED-HIV-12/11/2006

Synthesis and properties of G-quartet oligonucleotide-HIV-1 tat peptide conjugate

Kumashiro, T, Otake, T, Kawahata, T, Akagi, M, and Urata, H

Nucleic Acids Symp Ser (Oxf) 2006.(50): 177-178


2. 59584 HIV-LS-363; PUBMED-HIV-12/11/2006

2'-Deoxy-4'-C-ethynyl-2-fluoroadenosine: A nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma

Ohrui, H, Kohgo, S, Hayakawa, H, Kodama, E, Matsuoka, M, Nakata, T, and Mitsuya, H

Nucleic Acids Symp Ser (Oxf) 2006.(50): 1-2


3. 59585 HIV-LS-363; PUBMED-HIV-12/11/2006

Amino disaccharides having an alpha-(1->4) or a beta-(1->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat

Iguchi, T, Ishikawa, H, Matumoto, H, Mizuno, M, Goto, K, and Hamasaki, K

Nucleic Acids Symp Ser (Oxf) 2005.(49): 169-170


4. 59586 HIV-LS-363; PUBMED-HIV-12/11/2006

Synthesis and antiviral activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil against HIV-1

Maruyama, T, Kozai, S, Demizu, Y, Witvrouw, M, Pannecouque, C, Balzarini, J, Snoeck, R, Andrei, G, and De, Clercq E

Nucleic Acids Symp Ser (Oxf) 2004.(48): 3-4


5. 59587 HIV-LS-363; PUBMED-HIV-12/11/2006

Discovery of HIV-1 Protease Inhibitors with Picomolar Affinities Incorporating N-Aryl-oxazolidinone-5-carboxamides as Novel P2 Ligands

Ali, A, Reddy, GS, Cao, H, Anjum, SG, Nalam, MN, Schiffer, CA, and Rana, TM

J Med Chem 2006. 49(25): 7342-7356


6. 59588 HIV-LS-363; PUBMED-HIV-12/11/2006

Synthesis and anti-HIV evaluation of the novel 2-(m-chlorobenzyl)-4-substituted-7-methyl-1, 1, 3-trioxo-pyrazolo[4, 5-e] [1, 2, 4]thiadiazines

Yan, RZ, Liu, XY, Xu, WF, Pannecouque, C, Witvrouw, M, and De, Clercq E

Arch Pharm Res 2006. 29(11): 957-62


7. 59589 HIV-LS-363; PUBMED-HIV-12/11/2006

Anti-HIV Activity of Steric Block Oligonucleotides

Ivanova, G, Arzumanov, AA, Turner, JJ, Reigadas, S, Toulme, JJ, Brown, DE, Lever, AM, and Gait, MJ

Ann N Y Acad Sci 2006. 1082: 103-15


8. 59590 HIV-LS-363; SCIFINDER-HIV-12/4/2006

Design, synthesis and antiviral activity of cyclobutyl phosphonate nucleoside analogs as chain terminators against HIV

Li, Yongfeng, Schinazi, Raymond F, and Liotta, Dennis C

Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, United States, Sept. 10-14, 2006 2006.: MEDI-244

9. 59591 HIV-LS-363; PUBMED-HIV-12/11/2006

Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals

Markowitz, M, Morales-Ramirez, JO, Nguyen, BY, Kovacs, CM, Steigbigel, RT, Cooper, DA, Liporace, R, Schwartz, R, Isaacs, R, Gilde, LR, Wenning, L, Zhao, J, and Teppler, H

J Acquir Immune Defic Syndr 2006. 43(5): 509-515


10. 59592 HIV-LS-363; PUBMED-HIV-12/11/2006

Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol

Morris, KV, Chung, CH, Witke, W, and Looney, DJ

RNA Biol 2005. 2(1): 17-20


11. 59593 HIV-LS-363; PUBMED-HIV-12/11/2006


Choo, H, Beadle, JR, Kern, ER, Prichard, MN, Keith, KA, Hartline, CB, Trahan, J, Aldern, KA, Korba, BE, and Hostetler, KY

Antimicrob Agents Chemother 2006.


12. 59594 HIV-LS-363; SCIFINDER-HIV-12/4/2006

Hiv integrase inhibitors

Vacca, Joseph P, Wai, John S, Payne, Linda S, Isaacs, Richard CA, Han, Wei, Egbertson, Melissa, and Pracitto, Richard

PATENT: WO 2006121831 ISSUE DATE: 20061116

APPLICATION: 2006 PP: 122pp.

ASSIGNEE: (Merck & Co., Inc. USA

13. 59595 HIV-LS-363; PUBMED-HIV-12/11/2006

Interactions between Buprenorphine and Antiretrovirals. II. The Protease Inhibitors Nelfinavir, Lopinavir/Ritonavir, and Ritonavir

McCance-Katz, EF, Moody, DE, Smith, PF, Morse, GD, Friedland, G, Pade, P, Baker, J, Alvanzo, A, Jatlow, P, and Rainey, PM

Clin Infect Dis 2006. 43 Suppl 4: S235-46


14. 59596 HIV-LS-363; PUBMED-HIV-12/11/2006

Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine

McCance-Katz, EF, Moody, DE, Morse, GD, Friedland, G, Pade, P, Baker, J, Alvanzo, A, Smith, P, Ogundele, A, Jatlow, P, and Rainey, PM

Clin Infect Dis 2006. 43 Suppl 4: S224-34


15. 59597 HIV-LS-363; PUBMED-HIV-12/11/2006

From dihydroxypyrimidine carboxylic acids to carboxamide HIV-1 integrase inhibitors: SAR around the amide moiety

Petrocchi, A, Koch, U, Matassa, VG, Pacini, B, Stillmock, KA, and Summa, V

Bioorg Med Chem Lett 2006.


16. 59598 HIV-LS-363; SCIFINDER-HIV-12/4/2006

Polynucleotide and polypeptide sequences of HIV-1 Vif variants with antiviral activity and their therapeutic use

Bovolenta, Chiara

PATENT: WO 2006111866 ISSUE DATE: 20061026

APPLICATION: 2006 PP: 84pp.

ASSIGNEE: (Molmed SpA, Italy

17. 59599 HIV-LS-363; PUBMED-HIV-12/11/2006

Synthesis and in Vitro Biological Evaluation of Mannose-Containing Prodrugs Derived from Clinically Used HIV-Protease Inhibitors with Improved Transepithelial Transport

Roche, D, Greiner, J, Aubertin, AM, and Vierling, P

Bioconjug Chem 2006. 17(6): 1568-81


18. 59600 HIV-LS-363; PUBMED-HIV-12/11/2006

Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol

Figueiredo, A, Moore, KL, Mak, J, Sluis-Cremer, N, de, Bethune MP, and Tachedjian, G

PLoS Pathog 2006. 2(11): e119


19. 59601 HIV-LS-363; PUBMED-HIV-12/11/2006

Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G

Xiao, Z, Ehrlich, E, Luo, K, Xiong, Y, and Yu, XF

FASEB J 2006.


20. 59602 HIV-LS-363; SCIFINDER-HIV-12/4/2006

Piperidinylpiperidine derivatives useful as inhibitors of chemokine receptors and their preparation and pharmaceutical compositions

Chan, Tze-Ming, Cox, Kathleen, Feng, Wenqing, Miller, Michael W, Weston, Daniel, and Mccombie, Stuart

PATENT: WO 2006091534 ISSUE DATE: 20060831

APPLICATION: 2006 PP: 92pp.

ASSIGNEE: (Schering Corporation, USA

21. 59603 HIV-LS-363; WOS-HIV-12/04/2006

Synthesis of N,S-substituted 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives as potential anti-HIV agents

Brzozowski, Z and Slawinski, J

POLISH JOURNAL OF CHEMISTRY 2006. 80(11): 1807-1815, 9


22. 59604 HIV-LS-363; WOS-HIV-12/04/2006

Synthesis and anti-HIV activity of nevirapine prodrugs

Sriram, D, Yogeeswari, P, and Kshore, MRK

PHARMAZIE 2006. 61(11): 895-897, 3


23. 59605 HIV-LS-363; WOS-HIV-12/04/2006

Specific binding of a hexanucleotide to HIV-1 reverse transcriptase: a novel class of bioactive molecules

Mescalchin, A, Wunsche, W, Laufer, SD, Grohmann, D, Restle, T, and Sczakiel, G

NUCLEIC ACIDS RESEARCH 2006. 34(19): 5631-5637, 7


24. 59606 HIV-LS-363; WOS-HIV-12/04/2006

4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species

Summa, V, Petrocchi, A, Matassa, VG, Gardelli, C, Muraglia, E, Rowley, M, Paz, OG, Laufer, R, Monteagudo, E, and Pace, P

JOURNAL OF MEDICINAL CHEMISTRY 2006. 49(23): 6646-6649, 4


25. 59607 HIV-LS-363; SCIFINDER-HIV-12/4/2006

Substituted carbamates as HIV protease inhibitors and their preparation, pharmaceutical compositions and use in the treatment of HIV infection, AIDS and AIDS-related conditions

Mclean, Ed W and Miller, John Franklin

PATENT: WO 2006104646 ISSUE DATE: 20061005

APPLICATION: 2006 PP: 73pp.

ASSIGNEE: (Smithkline Beecham Corporation, USA

26. 59608 HIV-LS-363; WOS-HIV-12/04/2006

Part 13: Synthesis and biological evaluation of piperazine derivatives with dual anti-PAF and anti-HIV-1 or pure antiretroviral activity

Serradji, N, Bensaid, O, Martin, M, Sallem, W, Dereuddre-Bosquet, N, Benmehdi, H, Redeuilh, C, Lamouri, A, Dive, G, Clayette, P, and Heymans, F

BIOORGANIC & MEDICINAL CHEMISTRY 2006. 14(23): 8109-8125, 17


27. 59609 HIV-LS-363; WOS-HIV-12/04/2006

Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors

Yoshimura, K, Shibata, J, Kimura, T, Honda, A, Maeda, Y, Koito, A, Murakami, T, Mitsuya, H, and Matsushita, S

AIDS 2006. 20 (16): 2065-2073, 9


28. 59610 HIV-LS-363; WOS-HIV-12/11/2006

HIV infection of mononuclear cells is calcium-dependent

Anzinger, JJ, Mezo, I, Ji, X, Gabali, AM, Thomas, LL, and Spear, GT

VIRUS RESEARCH 2006. 122(1-2): 183-188, 6


29. 59611 HIV-LS-363; WOS-HIV-12/11/2006

Tristetraprolin inhibits HIV-1 production by binding to genomic RNA

Maeda, M, Sawa, H, Tobiume, M, Tokunaga, K, Hasegawa, H, Ichinohe, T, Sata, T, Moriyama, M, Hall, WW, Kurata, T, and Takahashi, H

MICROBES AND INFECTION 2006. 8(11): 2647-2656, 10


30. 59612 HIV-LS-363; WOS-HIV-12/11/2006

Inhibition of tRNA(3)(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationv

Guo, F, Cen, S, Niu, MJ, Saadatmand, J, and Kleiman, L

JOURNAL OF VIROLOGY 2006. 80(23): 11710-11722, 13


31. 59613 HIV-LS-363; WOS-HIV-12/11/2006

Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells

Oswald-Richter, K, Torres, VJ, Sundrud, MS, VanCompernolle, SE, Cover, TL, and Unutmaz, D

JOURNAL OF VIROLOGY 2006. 80(23): 11767-11775, 9


32. 59614 HIV-LS-363; WOS-HIV-12/11/2006

Synthesis of new substituted 4,5-dihydro-3H-spiro[1,5]-benzoxazepine-2,4 '-piperidine and biological properties

Laras, Y, Pietrancosta, N, Moret, V, Marc, S, Garino, C, Rolland, A, Monnier, V, and Kraus, JL

AUSTRALIAN JOURNAL OF CHEMISTRY 2006. 59(11): 812-818, 7


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023